Cargando…
Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis
Antigen presenting cells (APCs) play an important role in arthritis and APC specific gene therapeutic targeting will enable intracellular modulation of cell activity. Viral mediated overexpression is a potent approach to achieve adequate transgene expression levels and lentivirus (LV) is useful for...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563527/ https://www.ncbi.nlm.nih.gov/pubmed/23390530 http://dx.doi.org/10.1371/journal.pone.0055356 |
_version_ | 1782258204632154112 |
---|---|
author | van den Brand, Ben T. Vermeij, Eline A. Waterborg, Claire E. J. Arntz, Onno J. Kracht, Michael Bennink, Miranda B. van den Berg, Wim B. van de Loo, Fons A. J. |
author_facet | van den Brand, Ben T. Vermeij, Eline A. Waterborg, Claire E. J. Arntz, Onno J. Kracht, Michael Bennink, Miranda B. van den Berg, Wim B. van de Loo, Fons A. J. |
author_sort | van den Brand, Ben T. |
collection | PubMed |
description | Antigen presenting cells (APCs) play an important role in arthritis and APC specific gene therapeutic targeting will enable intracellular modulation of cell activity. Viral mediated overexpression is a potent approach to achieve adequate transgene expression levels and lentivirus (LV) is useful for sustained expression in target cells. Therefore, we studied the feasibility of lentiviral mediated targeting of APCs in experimental arthritis. Third generation VSV-G pseudotyped self-inactivating (SIN)-LV were injected intravenously and spleen cells were analyzed with flow cytometry for green fluorescent protein (GFP) transgene expression and cell surface markers. Collagen-induced arthritis (CIA) was induced by immunization with bovine collagen type II in complete Freund's adjuvant. Effect on inflammation was monitored macroscopically and T-cell subsets in spleen were analyzed by flow cytometry. Synovium from arthritic knee joints were analyzed for proinflammatory cytokine expression. Lentiviruses injected via the tail vein preferentially infected the spleen and transduction peaks at day 10. A dose escalating study showed that 8% of all spleen cells were targeted and further analysis showed that predominantly Ly6C+ and F4/80+ cells in spleen were targeted by the LV. To study the feasibility of blocking TAK1-dependent pathways by this approach, a catalytically inactive mutant of TAK1 (TAK1-K63W) was overexpressed during CIA. LV-TAK1-K63W significantly reduced incidence and arthritis severity macroscopically. Further histological analysis showed a significant decrease in bone erosion in LV-TAK1-K63W treated animals. Moreover, systemic Th17 levels were decreased by LV-TAK1-K63W treatment in addition to diminished IL-6 and KC production in inflamed synovium. In conclusion, systemically delivered LV efficiently targets monocytes and macrophages in spleen that are involved in autoimmune arthritis. Moreover, this study confirms efficacy of TAK1 targeting in arthritis. This approach may provide a valuable tool in targeting splenic APCs, to unravel their role in autoimmune arthritis and to identify and validate APC specific therapeutic targets. |
format | Online Article Text |
id | pubmed-3563527 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35635272013-02-06 Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis van den Brand, Ben T. Vermeij, Eline A. Waterborg, Claire E. J. Arntz, Onno J. Kracht, Michael Bennink, Miranda B. van den Berg, Wim B. van de Loo, Fons A. J. PLoS One Research Article Antigen presenting cells (APCs) play an important role in arthritis and APC specific gene therapeutic targeting will enable intracellular modulation of cell activity. Viral mediated overexpression is a potent approach to achieve adequate transgene expression levels and lentivirus (LV) is useful for sustained expression in target cells. Therefore, we studied the feasibility of lentiviral mediated targeting of APCs in experimental arthritis. Third generation VSV-G pseudotyped self-inactivating (SIN)-LV were injected intravenously and spleen cells were analyzed with flow cytometry for green fluorescent protein (GFP) transgene expression and cell surface markers. Collagen-induced arthritis (CIA) was induced by immunization with bovine collagen type II in complete Freund's adjuvant. Effect on inflammation was monitored macroscopically and T-cell subsets in spleen were analyzed by flow cytometry. Synovium from arthritic knee joints were analyzed for proinflammatory cytokine expression. Lentiviruses injected via the tail vein preferentially infected the spleen and transduction peaks at day 10. A dose escalating study showed that 8% of all spleen cells were targeted and further analysis showed that predominantly Ly6C+ and F4/80+ cells in spleen were targeted by the LV. To study the feasibility of blocking TAK1-dependent pathways by this approach, a catalytically inactive mutant of TAK1 (TAK1-K63W) was overexpressed during CIA. LV-TAK1-K63W significantly reduced incidence and arthritis severity macroscopically. Further histological analysis showed a significant decrease in bone erosion in LV-TAK1-K63W treated animals. Moreover, systemic Th17 levels were decreased by LV-TAK1-K63W treatment in addition to diminished IL-6 and KC production in inflamed synovium. In conclusion, systemically delivered LV efficiently targets monocytes and macrophages in spleen that are involved in autoimmune arthritis. Moreover, this study confirms efficacy of TAK1 targeting in arthritis. This approach may provide a valuable tool in targeting splenic APCs, to unravel their role in autoimmune arthritis and to identify and validate APC specific therapeutic targets. Public Library of Science 2013-02-04 /pmc/articles/PMC3563527/ /pubmed/23390530 http://dx.doi.org/10.1371/journal.pone.0055356 Text en © 2013 van den Brand et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article van den Brand, Ben T. Vermeij, Eline A. Waterborg, Claire E. J. Arntz, Onno J. Kracht, Michael Bennink, Miranda B. van den Berg, Wim B. van de Loo, Fons A. J. Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis |
title | Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis |
title_full | Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis |
title_fullStr | Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis |
title_full_unstemmed | Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis |
title_short | Intravenous Delivery of HIV-Based Lentiviral Vectors Preferentially Transduces F4/80+ and Ly-6C+ Cells in Spleen, Important Target Cells in Autoimmune Arthritis |
title_sort | intravenous delivery of hiv-based lentiviral vectors preferentially transduces f4/80+ and ly-6c+ cells in spleen, important target cells in autoimmune arthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563527/ https://www.ncbi.nlm.nih.gov/pubmed/23390530 http://dx.doi.org/10.1371/journal.pone.0055356 |
work_keys_str_mv | AT vandenbrandbent intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis AT vermeijelinea intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis AT waterborgclaireej intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis AT arntzonnoj intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis AT krachtmichael intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis AT benninkmirandab intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis AT vandenbergwimb intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis AT vandeloofonsaj intravenousdeliveryofhivbasedlentiviralvectorspreferentiallytransducesf480andly6ccellsinspleenimportanttargetcellsinautoimmunearthritis |